Skip to main content

For Industry

You are here

Company Profiles

  • Prolias Technologies Logo

    Prolias Technologies

    Prolias Technologies is an emerging molecular diagnostics company focusing on predictive and prognostic genetic cytology.

    Visit Website ]

    Category:Diagnostics

    Established:

  • Pataigan Logo

    Pataigin, LLC.

    Pataigin has developed a test that inexpensively identifies infections in less than an hour using bacterial lipid biomarkers.

     

    Visit Website ]

    Category:Diagnostics

    Established:

  • Myo Therapeutics Logo

    MYOtherapeutics

    Myotherapeutics is an early-stage biotherapeutics company focused on improving skeletal muscle function and improving mobility and quality of life in muscle-based diseases. The company has both a therapeutics division and a diagnostics division. Myotherapeutics is looking for investors to help accelerate the progress of its clinical development program.

    Category:Diagnostics

    Established:

  • Gliknik logo

    Gliknik Inc.

    Gliknik is a privately held biopharmaceutical company working to ease human suffering by creating new therapies for people living with cancer and immune disorders. 

    Visit Website ]

    Category:Therapeutics

    Established:

  • Glycomantra Logo

    GlycoMantra, Inc.

    Startup biotechnology firm leading the translational glycobiology research and interested in the development of carbohydrate-based therapeutics of cancer and infectious disease.

    Visit Website ]

    Category:Therapeutics

    Established:

  • OxyVita Logo

    OxyVita Inc.

    Oxyvita Inc. is a biotech company specializing in developing oxygen therapeutics and biomedical products utilizing proprietary Zero-Link™ hemoglobin polymerization process.

    Visit Website ]

    Category:Therapeutics

    Established:

  • Profectus Logo

    Profectus BioSciences

    Profectus is a clinical-stage biotechnology company pioneering a major evolutionary step in the design and development of preventive and therapeutic vaccines.

    Visit Website ]

    Category:Therapeutics

    Established:

  • Glycocept, Inc.

    Glycocept, Inc. is a UMB start-up company that has developed a novel technology, HyGly™, for modifying the binding of whole molecule antibodies to the inhibitory Fc receptor, FcgR2b.

    Category:Therapeutics

  • Inhalex Therapeutics, LLC

    Inhalex Therapeutics, LLC is a University of Maryland start-up that is based on a university developed technology for preventive and therapeutic strategies to address Allergy, Asthma and other Respiratory illnesses. The technology exploits proprietary immunotherapeutic compositions and the natural allergen-triggered immune response to alleviate respiratory illness associated symptoms including inflammation. The advantages of this technology over currently available strategies and therapies include, biocompatible method of intervention, and reduced dependence of anti-inflammatory drugs. Inhalex’s immediate goals are towards developing anti-allergy, asthma vaccines and eventually therapeutics. 

    Category:Therapeutics

    Established:

  • Educational and Scientific, LLC

    A commercial venture to conduct further research and development of medicinal plant isolates for the development of new pharmaceutical and “nutraceutical” products.

    Category:Therapeutics

Pages